Sotera Health (NASDAQ:SHC) Updates FY 2025 Earnings Guidance

Sotera Health (NASDAQ:SHC) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 0.810-0.860 for the period, compared to the consensus EPS estimate of 0.750. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on SHC. Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 16th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Sotera Health in a research note on Friday. Finally, Barclays boosted their price target on shares of Sotera Health from $17.00 to $19.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Sotera Health presently has an average rating of “Moderate Buy” and a consensus target price of $17.20.

Sotera Health Trading Up 2.1%

Shares of SHC stock traded up $0.34 during trading hours on Tuesday, hitting $16.95. 1,075,255 shares of the company’s stock traded hands, compared to its average volume of 1,377,008. The stock’s 50 day simple moving average is $16.14 and its 200 day simple moving average is $13.66. The stock has a market cap of $4.82 billion, a PE ratio of 212.14 and a beta of 1.82. Sotera Health has a 12 month low of $9.53 and a 12 month high of $17.78. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.02. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. On average, sell-side analysts anticipate that Sotera Health will post 0.61 EPS for the current year.

Insiders Place Their Bets

In other Sotera Health news, Director Pincus & Co. Warburg sold 12,000,000 shares of the firm’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $181,320,000.00. Following the completion of the sale, the director directly owned 61,822,952 shares in the company, valued at approximately $934,144,804.72. This trade represents a 16.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Michael P. Rutz sold 126,611 shares of Sotera Health stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $16.38, for a total transaction of $2,073,888.18. Following the transaction, the insider owned 450,204 shares of the company’s stock, valued at $7,374,341.52. This represents a 21.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 20,126,611 shares of company stock worth $304,273,888. 47.55% of the stock is currently owned by company insiders.

Institutional Trading of Sotera Health

Institutional investors and hedge funds have recently bought and sold shares of the company. California State Teachers Retirement System boosted its holdings in shares of Sotera Health by 1.6% in the second quarter. California State Teachers Retirement System now owns 144,003 shares of the company’s stock worth $1,601,000 after buying an additional 2,230 shares during the last quarter. Creative Planning boosted its holdings in shares of Sotera Health by 15.3% in the second quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after buying an additional 2,673 shares during the last quarter. Empowered Funds LLC boosted its holdings in shares of Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after buying an additional 2,845 shares during the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares during the last quarter. Finally, Treasurer of the State of North Carolina boosted its holdings in shares of Sotera Health by 4.5% in the second quarter. Treasurer of the State of North Carolina now owns 72,057 shares of the company’s stock worth $801,000 after buying an additional 3,134 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.